Sort
3,198 grants matching “mrna vaccine”
Active Immunotherapy with Pox Vector Modified DC
$213,630Duke University · P01 · FY2005 · CA
Proteomic Analysis of Hookworm Larval Activation
$213,600George Washington University · R21 · FY2005 · AI
Identification and Characterization of Signaling Pathways and Mediators Regulating Mast Cell-Related Disorders
$213,593Ana Olivera · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Measuring High Affinity Mucosal Antibody Responses
$213,485Maria Virginia Pascual · Baylor Research Institute · U19 · FY2010 · AI
HDV spread during chronic infection as a novel target for antiviral intervention
$212,910Severin O Gudima · University Of Kansas Medical Center · R21 · FY2013 · AI
Cellular RNA binding and regulation by NFX1-123 and its perturbation by high risk human papillomavirus E6
$212,625Rachel Adria Katzenellenbogen · Indiana University Indianapolis · R21 · FY2018 · AI
A participant-derived xenograft mouse model to study T-cell-mediated viral control and mRNA vaccine strategies
$211,875R. Brad Jones · Weill Medical Coll Of Cornell Univ · R21 · FY2023 · AI
ESAT-6 primes dendritic cells with reduced IL-12 and increased IL-23 production
$211,500Buka Samten · University Of Texas Hlth Ctr At Tyler · R21 · FY2012 · AI
Development of a novel model to study the effects of LINE-1 retrotransposons in disease and normal physiology using nanobodies
$211,485Pamela Cook · Mercer University Macon · R21 · FY2025 · GM
Measuring High Affinity Mucosal Antibody Responses
$211,351Maria Virginia Pascual · Baylor Research Institute · U19 · FY2011 · AI
Evaluation of iDMV-1.0: A Single Dose Self-Amplifying Vaccine for SARS-CoV-2
$211,108Devdoot Majumdar · University Of Vermont & St Agric College · P20 · FY2024 · GM
Aptamer mediated silencing of the spliceosome machinery to increase the immunogenicity of metastatic breast cancer
$210,978Paolo Serafini · University Of Miami School Of Medicine · R21 · FY2022 · CA
Small RNAs and Vibrio cholerae adaptation to different carbon sources
$210,520Jane May Liu · Drew University · R15 · FY2010 · AI
Development of nucleic acid-based vaccines against gonorrhea
$209,375Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R21 · FY2023 · AI
Harnessing Age-Associated B cells for a Universal Influenza Vaccine for the Aged
$209,375Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R21 · FY2024 · AI
Active Immunotherapy with Pox Vector Modified DC
$209,106Duke University · P01 · FY2004 · CA
Multivalent mRNA HIV vaccine using Envelopes from recently circulating viruses.
$208,875Dieter Mielke · Duke University · K01 · FY2025 · AI
Core C. Clinical Core/Human subjects
$208,815Brendan Joseph Kelly · University Of Pennsylvania · U19 · FY2023 · AI
Microvesicles as potential genetic biomarkers of brain tumors
$208,541Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2015 · CA
SARS-CoV-2: Pathogenesis and Countermeasure Development
$208,265Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Impact of mucosal adjuvanted vaccines on virus transmission in preclinical animal models for SARS-CoV-2 and influenza virus infection
$208,000Michael Schotsaert · Icahn School Of Medicine At Mount Sinai · R21 · FY2025 · AI
Microvesicles as potential genetic biomarkers of brain tumors
$207,781Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2016 · CA
Leveraging cytoplasmic transcription to develop self-amplifying DNA vaccines
$207,716Jean M Peccoud · Colorado State University · R21 · FY2023 · AI
Translational Control in Plasmodium Sexual Development
$207,544Pennsylvania State University-Univ Park · R01 · FY2001 · AI
Translational Control in Plasmodium Sexual Development
$207,457Pennsylvania State University-Univ Park · R01 · FY2002 · AI